TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17000360

Group type: EXPERIMENTAL
Intervention: Adenosine (0.14 mg/kg/min continuous infusion over 2 minutes)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Dobutamine (during DSE after adenosine test)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Dobutamine (in patients with dobutamine-induced wall-motion abnormalities)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Coronary angiography subgroup (12 patients with LAD stenosis)
Number of subjects: 47
Study: 14526269

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of 20 g Dipeptiven (8 g alanine and 13 g glutamine)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (normal saline only)
Number of subjects: 15
Study: 10911767

Group type: EXPERIMENTAL
Intervention: Ethanol with a mixed meal
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control (mixed meal without ethanol)
Number of subjects: 7
Study: 8776785

Group type: EXPERIMENTAL
Intervention: sabeluzole (SAB)
Number of subjects: 13
Study: 1470446

Group type: EXPERIMENTAL
Intervention: B-mode ultrasound
Number of subjects: 41

Group type: COMPARATOR
Intervention: Computed tomography (CT)
Number of subjects: 41
Study: 6385648

Group type: EXPERIMENTAL
Intervention: Ticlopidine
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study: 31072395

Group type: EXPERIMENTAL
Intervention: Cortical bone trajectory (CBT)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Traditional trajectory (TT)
Number of subjects: 240
Study: 29949494

Group type: EXPERIMENTAL
Intervention: Enzalutamide (160 mg once daily)
Number of subjects: 1401

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1401
Study: 26176644

Group type: EXPERIMENTAL
Intervention: Test adalimumab (Exemptia)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Reference adalimumab (Humira)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Both adalimumab preparations
Number of subjects: 120
Study: 25245213

Group type: EXPERIMENTAL
Intervention: Intervention group (n=249)
Number of subjects: 521

Group type: COMPARATOR
Intervention: Control group (n=272)
Number of subjects: 521
Study: 21741129

Group type: EXPERIMENTAL
Intervention: Twice-weekly resistance training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Once-weekly resistance training
Number of subjects: 0
Study: 20390972

Group type: EXPERIMENTAL
Intervention: Linguistic acculturation
Number of subjects: 2487
Study: 17825616

Group type: EXPERIMENTAL
Intervention: Indiplon 5 mg
Number of subjects: 358

Group type: EXPERIMENTAL
Intervention: Indiplon 10 mg
Number of subjects: 358

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 358
Study: 16047530

Group type: EXPERIMENTAL
Intervention: Depression at treatment entry
Number of subjects: 1450
Study: 12117873

Group type: EXPERIMENTAL
Intervention: Polymeric enteral diet (PEN1) containing 35 g of lipids per 1000 kcal, high in oleate (79%) and low in linoleate (6.5%)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Polymeric enteral diet (PEN2) with high linoleate (45%) and low oleate (28%)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Oral prednisone (1 mg/kg/day)
Number of subjects: 62
Study: 10408325

Group type: EXPERIMENTAL
Intervention: Creatine (Cr)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 20
Study: 7502086

Group type: EXPERIMENTAL
Intervention: Variable vacuum drainage system
Number of subjects: 120

Group type: COMPARATOR
Intervention: Continuous high vacuum drainage system
Number of subjects: 120
Study: 2109766

Group type: EXPERIMENTAL
Intervention: Behavioral therapy on urinary incontinence
Number of subjects: 133
Study: 7018336

Group type: EXPERIMENTAL
Intervention: Psyllium (n = 26)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (n = 34)
Number of subjects: 60
Study: 31257405

Group type: EXPERIMENTAL
Intervention: Creatine monohydrate (3 g/d)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 31709557

Group type: EXPERIMENTAL
Intervention: Cognitive defusion
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Cognitive reappraisal
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 88
Study: 27627789

Group type: EXPERIMENTAL
Intervention: Clamping group (intermittent clamping for 48 hours before removal)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Control group (removal without clamping)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Clamping group
Number of subjects: 210

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 210
Study: 26375805

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 321

Group type: EXPERIMENTAL
Intervention: Ambient stress group
Number of subjects: 321

Group type: EXPERIMENTAL
Intervention: Time stress group
Number of subjects: 321
Study: 23343912

Group type: EXPERIMENTAL
Intervention: Couple‐oriented posttest HIV counselling (COC)
Number of subjects: 1943

Group type: COMPARATOR
Intervention: Standard posttest HIV counselling
Number of subjects: 1943
Study: 21843686

Group type: EXPERIMENTAL
Intervention: 400 mcg buccal misoprostol
Number of subjects: 40
Study: 19507081

Group type: COMPARATOR
Intervention: Consumption of red wine (0.4 ml ethanol per kg per day for 7.5 days)
Number of subjects: 12
Study: 17713693

Group type: EXPERIMENTAL
Intervention: standard plus 'thought mapping' intervention
Number of subjects: 119

Group type: COMPARATOR
Intervention: standard intervention
Number of subjects: 119
Study: 15765004

Group type: EXPERIMENTAL
Intervention: Training in rapid serial naming of letter sounds
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Serial addition training
Number of subjects: 0

Group type: COMPARATOR
Intervention: No-training control group
Number of subjects: 0
Study: 11500583

Group type: EXPERIMENTAL
Intervention: Atropine before repeated defibrillation or post-shock atrial pacing
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Intravenous ajmaline
Number of subjects: 22

Group type: COMPARATOR
Intervention: Amiodarone therapy
Number of subjects: 22
Study: 9766172

Group type: EXPERIMENTAL
Intervention: Italian version of the Family Assessment Device (FAD), a 60-item questionnaire assessing family functioning.
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Factor analysis of the Italian version of the Family Assessment Device (FAD).
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Proposed seven-factor model of the instrument.
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Overall findings of the study.
Number of subjects: 340
Study: 7874853

Group type: EXPERIMENTAL
Intervention: Habitual sodium intake (30 mmol Na+ and 65 mmol K+)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: High sodium intake (+50 and +100 mmol/day)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Low sodium intake (-50 and -100 mmol/day)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Clinic arterial pressure at low sodium intake
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Additional week of fixed salt intake
Number of subjects: 14
Study: 3277342

Group type: EXPERIMENTAL
Intervention: Ginger root (1 g)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80

Group type: COMPARATOR
Intervention: Overall (Ginger root vs Placebo)
Number of subjects: 80
Study: 29134891

Group type: EXPERIMENTAL
Intervention: Baricitinib 4-mg
Number of subjects: 394

Group type: COMPARATOR
Intervention: Methotrexate
Number of subjects: 394

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 394
Study: 27340281

Group type: EXPERIMENTAL
Intervention: Tenapanor
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 24939853

Group type: EXPERIMENTAL
Intervention: Prototype electronic stethoscope
Number of subjects: 41

Group type: COMPARATOR
Intervention: Conventional stethoscope
Number of subjects: 41
Study: 23087737

Group type: EXPERIMENTAL
Intervention: Sugar-free chewing gum, chewed for 30 minutes 3 times a day for 4 days
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sugar chewing gum, chewed for 30 minutes 3 times a day for 4 days
Number of subjects: 16
Study: 20828492

Group type: EXPERIMENTAL
Intervention: Guided exploration with ergonomic chair layout (superior)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Guided exploration with ergonomic chair layout (inferior)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Free exploration with ergonomic chair layout (superior)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Free exploration with ergonomic chair layout (inferior)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Guided exploration (various conditions)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Free exploration (uninstructed)
Number of subjects: 50
Study: 18946938

Group type: EXPERIMENTAL
Intervention: Recombinant FSH (150 IU) started during the luteal phase
Number of subjects: 42
Study: 17941303

Group type: EXPERIMENTAL
Intervention: Fluoride sealant
Number of subjects: 294

Group type: COMPARATOR
Intervention: Nonfluoride sealant
Number of subjects: 294
Study: 14499752

Group type: EXPERIMENTAL
Intervention: Scopolamine
Number of subjects: 8

Group type: COMPARATOR
Intervention: Glycopyrrolate (placebo)
Number of subjects: 8
Study: 10972172

Group type: EXPERIMENTAL
Intervention: 20 mg omeprazole for 7 days
Number of subjects: 28

Group type: COMPARATOR
Intervention: No omeprazole treatment (Control)
Number of subjects: 28
Study: 9375331

Group type: EXPERIMENTAL
Intervention: Meperidine (1.5 mg/kg)
Number of subjects: 8
Study: 8229330

Group type: EXPERIMENTAL
Intervention: Self-help smoking cessation guide for firefighters (FF)
Number of subjects: 105

Group type: COMPARATOR
Intervention: American Lung Association (ALA) guide
Number of subjects: 105
Study: 3915058

Group type: EXPERIMENTAL
Intervention: Diclofensine 15 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Diclofensine 25 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Imipramine 25 mg
Number of subjects: 60
Study: 30114230

Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stents (EES)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bare-metal stents (BMS)
Number of subjects: 0
Study: 27422602

Group type: EXPERIMENTAL
Intervention: Two-day workshop with a five-hour follow-up session one month later
Number of subjects: 0

Group type: COMPARATOR
Intervention: Two-day workshop without follow-up
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control)
Number of subjects: 0
Study: 24528528

Group type: EXPERIMENTAL
Intervention: Stepping Up Program (intervention arm)
Number of subjects: 224

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 224
Study: 22842424

Group type: EXPERIMENTAL
Intervention: Cerium nitrate-silver sulfadiazine
Number of subjects: 154

Group type: COMPARATOR
Intervention: Silver sulfadiazine
Number of subjects: 154
Study: 20298997

Group type: EXPERIMENTAL
Intervention: Thrombolysis plus transcutaneous ultrasound (TUS)
Number of subjects: 396

Group type: COMPARATOR
Intervention: Thrombolysis alone (Control)
Number of subjects: 396
Study: 18702754

Group type: EXPERIMENTAL
Intervention: Intravenous morphine 10 mg
Number of subjects: 38

Group type: COMPARATOR
Intervention: Intramuscular morphine 10 mg
Number of subjects: 38
Study: 15943824

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg daily
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 12602656

Group type: EXPERIMENTAL
Intervention: Cognitive Trauma Therapy for Battered Women (CTT‐BW)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Delayed CTT‐BW
Number of subjects: 37
Study: 10226086

Group type: EXPERIMENTAL
Intervention: xemilofiban
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8722350

Group type: EXPERIMENTAL
Intervention: G-CSF administration on day 1 after transplantation (group 1)
Number of subjects: 35

Group type: COMPARATOR
Intervention: G-CSF administration on day 6 after transplantation (group 2)
Number of subjects: 35
Study: 2003666

Group type: EXPERIMENTAL
Intervention: Computer-assisted instruction (CAI)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Lecture
Number of subjects: 111

Group type: COMPARATOR
Intervention: Video
Number of subjects: 111
Study: 6362846

Group type: EXPERIMENTAL
Intervention: Single IV infusion of killed C. parvum vaccine
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 49
Study: 31201197

Group type: EXPERIMENTAL
Intervention: TRAM/DKP
Number of subjects: 393

Group type: COMPARATOR
Intervention: TRAM/paracetamol
Number of subjects: 393
Study: 29604474

Group type: EXPERIMENTAL
Intervention: Varenicline plus brief counseling
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo plus brief counseling
Number of subjects: 53
Study: 26876910

Group type: EXPERIMENTAL
Intervention: Modified Infant Feeding Styles Questionnaire (IFSQ) in English and Spanish
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Modified IFSQ in English and Spanish
Number of subjects: 303
Study: 24374400

Group type: EXPERIMENTAL
Intervention: Disposable Group
Number of subjects: 102

Group type: COMPARATOR
Intervention: Reusable Group
Number of subjects: 102
Study: 23020253

Group type: EXPERIMENTAL
Intervention: SAXA-MET (saxagliptin 5 mg/day added to metformin 1500 mg/day)
Number of subjects: 286

Group type: COMPARATOR
Intervention: MET-UP (metformin uptitration to a maximum dose of 2500 mg/day)
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: SAXA-MET
Number of subjects: 286

Group type: COMPARATOR
Intervention: MET-UP
Number of subjects: 286
Study: 20497522

Group type: EXPERIMENTAL
Intervention: Motivational interviewing for weight feedback
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Tailored package intervention
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1500
Study: 17905274

Group type: EXPERIMENTAL
Intervention: Isoflurane treatment (0.5 MAC)
Number of subjects: 280

Group type: COMPARATOR
Intervention: Control group (no isoflurane treatment)
Number of subjects: 280
Study: 14996603

Group type: EXPERIMENTAL
Intervention: L-arginine and vitamin C infusion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: L-arginine infusion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitamin C infusion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: L-arginine and vitamin C together infusion
Number of subjects: 0
Study: 12133744

Group type: EXPERIMENTAL
Intervention: Group 3 (print information + discussion of local strategies)
Number of subjects: 554
Study: 9513803

Group type: EXPERIMENTAL
Intervention: Neelambari raga
Number of subjects: 8

Group type: COMPARATOR
Intervention: Kalyani raga
Number of subjects: 8
Study: 8580224

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 56

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 56
Study: 2563314

Group type: EXPERIMENTAL
Intervention: Esmolol 80 mg I.V. bolus followed by 12 mg/min infusion
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 4942741

Group type: EXPERIMENTAL
Intervention: Clofazimine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dapsone
Number of subjects: 0
Study: 31733088

Group type: EXPERIMENTAL
Intervention: Intravenous ketamine 0.2 mg/kg
Number of subjects: 18

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 18
Study: 31018018

Group type: EXPERIMENTAL
Intervention: Bilateral custom‐made ankle‐foot orthoses (AFOs) and fitted walking shoes
Number of subjects: 44

Group type: COMPARATOR
Intervention: Fitted walking shoes
Number of subjects: 44

Group type: COMPARATOR
Intervention: Comparison between IG and CG
Number of subjects: 44
Study: 28528566

Group type: EXPERIMENTAL
Intervention: Aerobic training
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 90
Study: 26083698

Group type: EXPERIMENTAL
Intervention: 12-week recreational skiing intervention
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (no skiing intervention)
Number of subjects: 27
Study: 23515377

Group type: EXPERIMENTAL
Intervention: Fibrin sealant VH S/D 4 S-Apr (ARTISS)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Standard-of-care (SoC) treatment
Number of subjects: 45
Study: 21644298

Group type: EXPERIMENTAL
Intervention: Acupuncture at Shiqizhui (EX-B 8) only
Number of subjects: 38

Group type: COMPARATOR
Intervention: Multi-acupoints (Shiqizhui (EX-B 8), Sanyinjiao (SP 6), Diji (SP 8), Ciliao (BL 32))
Number of subjects: 38
Study: 20088412

Group type: EXPERIMENTAL
Intervention: Electroacupuncture at Zusanli (ST 36) combined with intravenous drip of Granisetron
Number of subjects: 246

Group type: COMPARATOR
Intervention: Intravenous drip of Granisetron only
Number of subjects: 246
Study: 15716033

Group type: EXPERIMENTAL
Intervention: Epilepsy surgery
Number of subjects: 139

Group type: COMPARATOR
Intervention: Control group with prolonged medical treatment for intractable epilepsy
Number of subjects: 139

Group type: COMPARATOR
Intervention: General population controls
Number of subjects: 139
Study: 10678500

Group type: EXPERIMENTAL
Intervention: Ginkgo biloba extract containing 33% Ginkgo flavone glycosides
Number of subjects: 0

Group type: COMPARATOR
Intervention: Superoxide dismutase (SOD)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Kaempferol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quercetin
Number of subjects: 0
Study: 9119715

Group type: EXPERIMENTAL
Intervention: Cold therapy (ice pack placed on injection site for 15 min prior to injection)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (injections according to hospital protocol)
Number of subjects: 40
Study: 1826096

Group type: EXPERIMENTAL
Intervention: Gestodene
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Desogestrel
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Gestodene and Desogestrel
Number of subjects: 10
Study: 7040930

Group type: EXPERIMENTAL
Intervention: High dose methotrexate (HDMTX) with folinic acid (FA) rescue (6-hour infusion)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: High dose methotrexate (HDMTX) with folinic acid (FA) rescue (24-hour infusion)
Number of subjects: 28
Study: 31630504

Group type: EXPERIMENTAL
Intervention: Perifascial technique (20 mL of 10 mg/mL mepivacaine along the latissimus dorsi and superficial axillary fascia)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Perineural technique (20 mL of 10 mg/mL mepivacaine around radial, median, ulnar and musculocutaneous nerves)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 42
Study: 30689703

Group type: EXPERIMENTAL
Intervention: Neratinib 240 mg/day
Number of subjects: 2840

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2840
Study: 29031002

Group type: EXPERIMENTAL
Intervention: Resistance training (RT) program for 12 weeks
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group (CG) with no physical exercise for 12 weeks
Number of subjects: 53
Study: 27920508

Group type: EXPERIMENTAL
Intervention: WB‐EMS&P (whole-body electromyostimulation with dietary supplementation)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: WB‐EMS (whole-body electromyostimulation without dietary supplementation)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 75
Study: 24145800

Group type: EXPERIMENTAL
Intervention: McGrath videolaryngoscope
Number of subjects: 28

Group type: COMPARATOR
Intervention: Flexible fibreoptic endoscope (FFE)
Number of subjects: 28
Study: 22850565

Group type: EXPERIMENTAL
Intervention: Imatinib treatment
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Volume of liver metastases
Number of subjects: 50
Study: 20668976

Group type: EXPERIMENTAL
Intervention: Self-reevaluation intervention (Project Positive Living through Understanding and Support)
Number of subjects: 143
Study: 17069836

Group type: EXPERIMENTAL
Intervention: Radiofrequency catheter ablation of the slow pathway
Number of subjects: 112
Study: 16254468

Group type: EXPERIMENTAL
Intervention: Diabetic children
Number of subjects: 140

Group type: COMPARATOR
Intervention: Non-diabetic controls
Number of subjects: 140
Study: 11888463

Group type: EXPERIMENTAL
Intervention: Stapled hemorrhoidectomy (Longo technique)
Number of subjects: 40
Study: 9705161

Group type: EXPERIMENTAL
Intervention: Capsaicin 0.05% applied three times daily for 5 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Capsaicin pretreatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-pretreated skin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Capsaicin-pretreated skin
Number of subjects: 0
Study: 8537137

Group type: EXPERIMENTAL
Intervention: Cefixime suspension (8 mg/kg/day, b.i.d., for 10 days)
Number of subjects: 510

Group type: COMPARATOR
Intervention: Amoxicillin-clavulanate suspension (80 mg/kg/day, t.i.d., for 10 days)
Number of subjects: 510
Study: 2233283

Group type: EXPERIMENTAL
Intervention: Aspartame in capsules (20 mg/kg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Aspartame in solution (20 mg/kg)
Number of subjects: 20
Study: 30806868

Group type: EXPERIMENTAL
Intervention: Polydrug use (both partners exhibited the behavior)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Polydrug use (only respondent exhibited the behavior)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Binge drinking (both partners exhibited the behavior)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Binge drinking (only respondent exhibited the behavior)
Number of subjects: 320
Study: 28197849

Group type: EXPERIMENTAL
Intervention: Myofascial therapy in addition to a standard physical therapy program
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo intervention in addition to a standard physical therapy program
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Standard physical therapy program (both groups)
Number of subjects: 50
Study: 27124003

Group type: EXPERIMENTAL
Intervention: Lithium carbonate tablets from 2 different Chinese pharmaceutical manufacturers
Number of subjects: 20

Group type: COMPARATOR
Intervention: Lithium carbonate tablets
Number of subjects: 20
Study: 24325663

Group type: EXPERIMENTAL
Intervention: deproteinized bovine bone mineral (DBBM)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: β‐tricalcium phosphate (β‐TCP)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Both DBBM and β‐TCP
Number of subjects: 38
Study: 22512826

Group type: EXPERIMENTAL
Intervention: Antibiotic prophylaxis
Number of subjects: 364

Group type: COMPARATOR
Intervention: No antibiotic prophylaxis
Number of subjects: 364
Study: 20881359

Group type: EXPERIMENTAL
Intervention: Lidocaine
Number of subjects: 26

Group type: COMPARATOR
Intervention: Prilocaine
Number of subjects: 26